Genomics and Beckman Coulter Life Sciences, announce the commercial availability of a new solution to automate single cell gene expression workflows.

Graft composition was comparable between the study and a contemporaneous control group mobilized using G-CSF and plerixafor, including subsets of CD34+ CD90+ CD45RA− cells, T cells, and natural ...